Occult Breast Cancer Patients with Mastectomy Had Better Prognosis than those with Breast Conserving Therapy - supplementary material

Supplementary Figure 1. Univariate Kaplan-Meier DFS survival plots of (A) surgery, (B) AJCC N stage, (C) endocrine therapy, and (D) radiotherapy in pathologically diagnosed 70 patients with OBC using Cox Regression Mode
Supplementary Figure 2. Univariate Kaplan-Meier DFS survival plots of mastectomy+ALND vs. BCT+ALND in the luminal B subgroup
Supplementary Figure 3. Univariate Kaplan-Meier DFS survival plots of mastectomy+ALND vs. BCT+ALND in the AJCC N0-N1 stage subgroup
Supplementary Figure 4. Univariate Kaplan-Meier OS and DFS survival plots of the involved fields of axilla, whole breast, and axilla and whole breast in the radiotherapy subgroup
Supplementary Figure 5. Nomogram model of DFS in 70 pathologically diagnosed OBC patients
Supplementary Table 1. Univariate survival analysis of OS and DFS of OBC patients using Kaplan-Meier method.
Supplementary Table 2. Univariate and multivariate survival analysis of OS and DFS of OBC patients using Cox Regression Model
Supplementary Table 3. Univariate and multivariate survival analysis of OS and DFS of 71 pathologically diagnosed OBC patients using Cox regression model
Supplementary Table 4. Univariate survival analysis comparing Mastectomy+ALND vs. BCT+ALND of OS and DFS in the four molecular subtypes and AJCC N stage subgroups in OBC patients using Kaplan-Meier method
Supplementary Table 5. Comparisons of potential prognostic factors in the occult breast cancer patients with mastectomy+ALND between the group with radiotherapy and without radiotherapy.
Supplementary Table 6. Comparisons of potential prognostic factors in the occult breast cancer patients with BCT+ALND between the group with radiotherapy and without radiotherapy.